Sorry to be somewhat late in replying but as a former long term holder of this quality stock run by quality management may I offer some points;
PME has always traded outside the bounds of what is typically textbook metrics applied to quality companies and, investors have been happy to pay the appropriate share price - albeit at what some may perceive as being a premium. Indeed most industry commentators over the years have referred to the company as being a gold class investment.
For instance, only last year, in April 2021 their valuation increased by $1.4B to $7.3B and this year the price has suffered as a result of global inflation.
Finally, adding in a weekly chart I would be content to suggest that it could potentially bounce from this level.
- Forums
- ASX - By Stock
- PME
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-36
Featured News
Add PME (ASX) to my watchlist
(20min delay)
|
|||||
Last
$209.86 |
Change
5.000(2.44%) |
Mkt cap ! $21.93B |
Open | High | Low | Value | Volume |
$207.24 | $209.86 | $205.60 | $24.72M | 118.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 238 | $209.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$209.95 | 280 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47 | 208.970 |
2 | 46 | 208.000 |
1 | 24 | 206.350 |
2 | 155 | 205.000 |
3 | 61 | 204.900 |
Price($) | Vol. | No. |
---|---|---|
209.950 | 280 | 1 |
209.990 | 500 | 1 |
210.000 | 205 | 4 |
210.220 | 300 | 1 |
210.250 | 5 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PME (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online